Stock Spotlight Archives - Page 93 of 379

FridayAug 12, 2022 1:08 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Promoting Artists’ Independence, Revenue Generation

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists. The acquisition completed the company’s flagship offering, Fan Pass Live. “Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution and marketing services without the control of music labels pulling the strings or eating up revenue… The 360-degree suite of Fan Pass Live, Artist Republik and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman,…

FridayAug 12, 2022 12:40 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain. Recently, the company announced that the FDA had approved an amendment to the study’s protocol, boosting its Berubicin clinical development program. “The amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapy,” explains a recent article. “The key objectives of the amendment, according to CNS Pharmaceuticals…

WednesdayAug 10, 2022 3:01 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Increasing Presence on Revolutionary Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) has launched 17 active nodes on the Bitcoin Lightning Network, spanning multiple countries to facilitate faster transactions with lower fees. “The first node (US-West) was launched in November 2021, around the same time the company launched its platform-as-a-service (‘PaaS’) offering, lqwd.tech. LQwD’s PaaS solution allows users worldwide to send and receive Bitcoin on the Lightning Network instantly, securely and inexpensively. The company expects the Lightning Network to be a force for global change and the monetary exchange of the future … with this expectation, it has invested its own Bitcoin assets into the Lightning…

MondayAug 08, 2022 2:58 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Working to Build Framework for Carbon-Negative Energy Production

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), a leading Canadian renewable energy company and renewable natural gas (“RNG”) platform, is working to develop the sustainable infrastructure that contributes to carbon-negative energy production. “EverGen has been methodically and quickly expanding its footprint across Canada under the moniker of ‘Canada’s Renewable Natural Gas Infrastructure Platform.’ At the end of December 2020, EverGen raised over $30 million and acquired two RNG projects in British Columbia to get operations rolling. In 2021, EverGen bought Fraser Valley Biogas Ltd., nailed down offtake agreements for its RNG with FortisBC, a unit of Newfoundland-based Fortis Inc., Canada’s biggest private…

FridayAug 05, 2022 1:30 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc. Standing Distinct in Battle Against Rising Global Temperatures

GeoSolar Technologies is taking an innovative approach to redefining how people heat, cool, cook, power, and purify homes with 100% sustainable energy sources. “In fact, ‘There may not be a company in the climate technology industry that is doing more in the battle against rising global temperatures,’ according to Marilyn Lopez, partner and co-founder of TAG Collective. TAG is overseeing marketing efforts for GeoSolar Technologies related to the company’s upcoming Reg A+ offering to raise capital ahead of going public,” a recent article reads. “The Denver-based company’s patent-pending SmartGreen(TM) system harnesses energy from the earth and sun to naturally power…

FridayAug 05, 2022 1:20 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Continues Strides to Push Gross Margins by Optimizing Product Offerings

FingerMotion (NASDAQ: FNGR) reported a 37% year-over-year growth in revenue for the financial year ended Feb. 28, 2022 (“FY2022”). “One of our key initiatives is to keep pushing gross margins higher, and we have been quite successful by optimizing our product offerings,” a recent article quotes CEO Martin Shen’s comments from the release of the FY2022 results. Regarding the results, Shen is quoted saying, “We have been able to steadily increase our margins by optimizing our product mix between Top-up and SMS. While our biggest challenge continues to be access to non-dilutive capital, we remain steadfast in our belief that…

FridayAug 05, 2022 1:02 pm

QualityStocksNewsBreaks – Why Cub Crafters Inc. Is ‘One to Watch’

Cub Crafters (typically styled CubCrafters), based at McAllister Field Airport in Yakima, Washington, is the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft. “The company was founded in 1980 to build parts and supplementary type certificate (‘STC’) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (‘FAA’) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production…

ThursdayAug 04, 2022 1:14 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Reports Positive Results from Research on Novel Liposomes

Silo Pharma (OTCQB: SILO) recently announced it had produced an initial batch of SPU-21 liposomes for a rheumatoid arthritis study conducted by Frontage Laboratories, a contract research organization (“CRO”). “Recent research by the company revealed that SPU-21 liposomes have the ability to target inflamed epithelium, suggesting they can be used to target drug delivery. Further, SPU-21 can potentially be used to develop fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis. According to the research, this approach may enhance therapeutic effects and decrease potential toxicity despite systemic administration of the drug,” a recent article reads. “In addition, Silo recently announced…

ThursdayAug 04, 2022 1:05 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Teaming up to Guide Commercial Real Estate Owners in Creating New Revenue Opportunities

Correlate Infrastructure Partners (OTCQB: CIPI) is a purpose-built energy use optimization company based in the United States. CIPI has made it its mission to develop green utility solutions for the commercial real estate industry to enable buildings and other corporate facilities to help contribute to a climate solution. “The company works to provide advisory assistance on acquisitions and project development to commercial solar industry clients and to back that up with development and financing resources for commercial clients looking for clean energy facility upgrades. CIPI’s subsidiaries, Correlate and Solar Site Design, use data analysis and a commitment to transparency to…

WednesdayAug 03, 2022 2:34 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate Its CYB004 Clinical Development Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition of a phase 1 N,N-Dimethyltryptamine (“N,N-DMT”) study, the largest DMT study to date. The study provides key data relating to the company’s proprietary CYB004 substance with the potential to effectively treat anxiety disorders. “The phase 1 EBRX-101 study, now named CYB004-E, was acquired from Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) FSE: 1XU1) through Cybin IRL Limited, Cybin’s wholly owned subsidiary… The adaptive, randomized, double-blinded, placebo-controlled, single-ascending-dose study produced notable results. According to the…

Site Search

Company Search

Category: Stock Spotlight